Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age21+
SponsorNational Cheng-Kung University Hospital
About this trial
Transvaginal or transabdominal surgeries are current choices of uterus-preserving surgeries for pelvic organ prolapse.
Laparoscopic lateral uterine suspension, a modified surgical approach of uterine suspension from bilateral abdominal wall fascia, performed with expected safety and simplicity of surgery besides advantages including small wound incision and fast recovery in laparoscopic surgeries. This trial aim to discuss the therapeutic efficacy, long term safety, and adverse events of laparoscopic lateral uterine suspension and compare with the conventional transvaginal sacrospinous ligament fixation with native tissue repair.
Eligibility criteria
Qualifiers
older than 21 years old.
uterine prolapse stage 2 at least, defined by C point distal to -1cm by POP-Q system.
patients willing to receive a uterine-preserving surgery for pelvic organ prolapse, and is suitable for anesthesia after evaluation.
patients who had or had not received conservative treatments for pelvic organ prolapse.
Disqualifiers
patient who had received a previous hysterectomy, or is planning on concomitant hysterectomy in the surgery for pelvic organ prolapse.
patient who had received a previous surgery for pelvic organ prolapse.
patient with history of adverse events following a synthetic mesh.
patients with chronic or acute pelvic pain.
Trial design
Treatments tested in this trial
- Laparoscopic uterine lateral suspension
- Transvaginal sacrospinous fixation
Treatment groups
90 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov